very differently. Many severity scoring systems have been generated, most focusing on the severity of reactions following exposure to a limited group of allergens. They are heterogeneous in format, none has used an accepted developmental approach, and none has been validated. Their wide range of outcome formats has led to difficulties with interpretation and application. Therefore, there is a persisting need for an appropriately developed and validated severity scoring system for allergic reactions that work across the range of allergenic triggers and address the needs of different stakeholder groups. We propose a novel approach to develop and then validate a harmonized scoring system for acute allergic reactions, based on a datadriven method that is informed by clinical and patient experience and other stakeholders' perspectives. We envisage two formats: (i) a numerical score giving a continuum from mild to severe reactions that are clinically meaningful and are useful for allergy healthcare professionals and researchers, and (ii) a three-grade-based ordinal format that is simple enough to be used and understood by other professionals and patients. Testing of reliability and validity of the new approach in a range of settings and populations will allow eventual implementation of a standardized scoring system in clinical studies and routine practice.
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| INTRODUCTION
IgE-mediated allergy affects people of all age groups across the world. 1 views about the apparent severity of the same reaction. These differences are important because the severity of a reaction guides both the immediate and long-term management of the patient. 3 It is therefore vital to be able to describe accurately the severity of previous reactions to optimize both immediate care decisions and ongoing patient management. Moreover, there is a need to grade severity, to standardize patient monitoring, and to define severity in participants in clinical studies, such as immunomodulation therapy, as well as facilitate risk assessment and management by, for example, the food industry and public health authorities. Requires a simple, easy-to-remember system to facilitate emergency management.
Allergy healthcare specialists
Assessment for acute and long-term management, risk assessment, and education of patients.
To document the reaction in detail to allow documentation and communication.
Food industry Increase awareness on anaphylaxis, risk assessment of products, and risk management Client-facing sectors (eg, restaurants) need a simple framework to manage allergic reactions. Risk assessors and managers need numerical scores that can be incorporated into probabilistic models of allergen risk.
Public health authorities Increase awareness on anaphylaxis, to assess outcomes of health policies, funding allocation, health policy prioritization, and cost-effectiveness assessment, improve allergic reaction codification, facilitate epinephrine availability, education on anaphylaxis management for lay people (eg, teachers, children day carers, and airline cabin crew)
Require a simple, easy-to-understand system that can be used by nonhealthcare professionals. For regulators, a more sophisticated numerical score incorporating probabilistic models of allergen risk would be required.
Food, hospitality, and catering industries
Increase awareness on anaphylaxis, risk assessment of products, and risk management
The food industry (eg, restaurants) needs a simple framework to manage allergic reactions. Risk assessors and managers need numerical scores that can be incorporated in probabilistic models of allergen risk.
Researchers
Harmonize terminology in observational and interventional studies, aid comparison of data, and interpretation of mechanistic studies System needs to document the reaction with increased granularity to allow definition, segmentation, and analysis 
| THE MEANIN G OR PERCEPTION OF SEVERITY IN RELATION TO ACUTE ALLERGIC REACTIONS
The term severity has different meanings to different subgroups of patients, to healthcare professionals, researchers, the food industry, public health authorities, or other stakeholders. All these perspectives need to be explored to understand the differing needs and concerns of each of these groups. A dictionary definition describes severity "as the degree of affliction suffered due to a condition or stressor" or "the degree of pain or harm from a medical condition".
A severe reaction should be considered either as one causing disruption to the activities of daily life or as an event that leads to an otherwise unanticipated healthcare utilization.
It is important to recognize that "severity" is a continuum, which may be dynamic: A person having a mild reaction (eg, mild angioedema) may progress to severe symptoms (eg, bronchospasm) within a few minutes. There may be temporal differences in severity from one allergen exposure event to another, possibly due to a genuine change in a patient's clinical status, a change in dose of allergen or the addition of augmentation or cofactors that can exacerbate allergic reactions. [16] [17] [18] Perceived severity depends on subjective interpretation of symptoms and can also vary depending on what else may be going on in an individual's life (eg, stress at work or home, other chronic disorders, level of risk aversion, and cofactors) and on whether they are a patient or a carer.
We believe it is helpful to consider severity of allergic reactions from the perspective of each of the key stakeholders.
Allergic individuals and their carers: patients and their carers tend
to under-or overestimate the potential severity of severe allergic reactions, and they may not seek medical help. 19 For example, clinical experience shows that families often consider angioedema in the context of an allergic reaction to be much more significant than mild wheeze; their allergy-experienced physicians are likely to disagree considering wheeze to be more severe (and potentially life-threatening). Patients and their carers may be used to wheezing with viral infections and therefore treat allergen-induced wheezing with their usual asthma treatments not appreciating that, in this context, the bronchospasm and resulting symptoms may worsen rapidly. Any disruption to daily life can be reasonably considered by the family to be a significant or severe event: for example, missing a day of school due to urticaria or visiting the emergency department due to anaphylaxis.
Family doctors rarely encounter allergic reactions and may not have had training, the clinical experience, or sufficient time within the consultation to assess their severity. Epinephrine (adrenaline) may be prescribed when it is not indicated, or a patient may be referred to the emergency department when an allergic reaction is not potentially life-threatening. Conversely, the severity may be underappreciated and the reaction only treated with antihistamines and corticosteroids instead of epinephrine.
20
Emergency department physicians and first responders in the community may not appreciate the allergic origin of clinical scenarios that they encounter. The differential diagnosis for anaphylaxis is very broad. 21 So, in the absence of any objective point of care diagnostic test, the constellation of symptoms and signs caused by severe multisystem allergic reactions (anaphylaxis) must be recognized if correct emergency treatment is to be initiated.
Allergy specialists are trained to recognize the clinical spectrum of allergic diseases and to pragmatically evaluate their patients' previous reactions. An accurate evaluation of severity is required to determine emergency treatment and personalize care plans. Most allergists do not see their patients during acute allergic reactions so there is a need to accurately, but retrospectively, assess the potential severity.
Health psychologists need to be able to separate the physiological symptoms of allergic disease from the psychological impact and determine the impact that is due to any psychological comorbidities.
Such an analysis has profound implications for correct treatment and management and for alleviating patient/parent anxiety and concerns.
Food industry and public health bodies may consider a severe outcome to be any change in a person's quality of life, unscheduled access to medical care, loss of time at work, school, or studies.
While there are clear differences between the perspectives and needs of these different stakeholders, there is also considerable overlap and this could feed into a harmonized approach. A harmonized severity scoring system for allergic reactions ideally needs to take into account the perceptions and needs of different stakeholders. Grades of severity should be distinct to facilitate their utilization F I G U R E 1 Illustration of how a severity scoring system could be used to guide the management of acute allergic reactions by patients, parents, healthcare professionals, and other relevant groups. Ensuring that these grades make sense to other groups who may use the system will be a challenge, but it is essential for any proposed harmonized system that it is accepted by all stakeholders.
| WH AT SEVE RITY SCORIN G SYSTEMS ARE CURRENTLY AVAILABLE?
Different scoring systems have been proposed to assess the severity of acute allergic reactions. These address allergic reactions induced by food, 6 14, 20 or related to number of organs involved and treatment plan. 11 Furthermore, some of the classification systems only cover the most severe allergic reactions (ie, anaphylaxis), 5, 15 while others are designed for a wider spectrum of reactions. 9, 27, 30 Almost all current scoring systems are organ-specific, dividing symptoms and signs according to origin (ie, the skin, respiratory, gastrointestinal, cardiovascular, and nervous system), there is less consistency in terms of which symptoms and signs are included. Skin symptoms usually include pruritus, urticaria, angioedema, and flushing/rash. Gastrointestinal features consist mostly of subjective symptoms (eg, oral allergy syndrome, nausea, and abdominal pain), emesis, and diarrhea. Cardiovascular features include change in heart rate (from tachycardia to cardiac arrest) and different grades of hypotension. Neurological features are less consistent, with grades of anxiety and consciousness (from reduced activity level to total loss of consciousness). The biggest discrepancies are found in respiratory symptoms where some only apply airway obstruction, 14 while others incorporate different levels of laryngeal symptoms, wheezing, dyspnea, asthma, cyanosis, and respiratory arrest. 9 Symptoms from upper airways (ie, nose and eyes) are covered by some 9, 25, 28 and excluded by others. 4, 12, 23 No approach has included a full set of symptoms and signs and the heterogeneity of scoring of each symptom/sign is pronounced, with classification ranging from "present" to "mild/moderate/severe" to the 6-grade comprehensive Japanese ASCA system 31 (not available in English). A more limited number of grades (eg, mild, moderate, and severe or give epinephrine/do not give epinephrine) may be more useful for patients and nonallergy specialists.
However, for research purposes, and to inform and validate more simple systems, it may be preferable to have a numerical severity score with more gradations.
Comparison across historical approaches is difficult, but not were any specifically designed for the proposed comparisons.
| WHAT ARE THE CHALLEN GE S ASSOCIATED WITH DEVELOPING A SINGLE UNIFIED SEVERITY SCORING SYSTEM FOR ACUTE ALLERGIC REACTIONS?
The key problem in developing an allergic reaction severity score is the lack of a reliable, evidence-based, gold standard criterion standard that can be used as a reference for derivation and validation. This is one of the research needs being addressed by the iFAAM study 32 and may provide a better outcome measure to use in generating a severity score. This in itself would need validation across the breadth of clinical allergy. Extending these systems to all allergic reactions is challenging, not least because of possible bias from a nonrepresentative sample, with implications for both reliability and validity. Furthermore, the existing allergy nomenclature is far from being harmonized. 33 A better insight into the disease mechanisms underlying different allergic reactions and an endotype-driven approach 34 would help to develop a common methodology across the huge spectrum of allergic disease. The range of allergic triggers, clinical presentations, and ages plus the potential geographic diversity creates issues with adequate validation of any scoring system in all the key target populations.
| A PROPOSED APPR OACH TO DEVELOPING A SEVERITY SCORING SYSTEM
An ideal scoring system for the severity of allergic reactions would Scores from the two formats should each be able to be mapped onto each other. Additionally, scores associated with less severe symptoms or signs should be lower than scores associated with more severe ones.
In the simpler format, severity would be classified into different grades. Such an approach would be mainly intended for the more Table 2) . This 3-level classification system could, for example, be graphically represented with a 3-color code, yellow-orange-red for grades 1-3 (see Table 2 ) that would facilitate understanding and wide dissemination in the lay and nonspecialist healthcare communities. It would also facilitate individualized management with patients with different risk profiles advised to use epinephrine at different grades.
In the more nuanced numerical format, the proposed severity scoring system would facilitate the needs of researchers and provide a detailed description of, for example, food challenge outcomes. If the resulting score could be interpreted in relation to the simpler grading system, flexibility would be enhanced making it useful to a wider number of stakeholders. The score would be generated using a list of variables derived by consensus by a multidisciplinary panel of experts. A numerical weighting would be applied to each variable; this weighting could be derived in step 1 by expert consensus (a subjective score) and then in step 2 by utilizing a large database of clinical data from patients experiencing acute allergic reactions (an objective score).
A data-driven approach to generate an objective score must be incorporated as it is more likely to produce a valid model. This lends itself to being integrated into, for example, probabilistic models being developed for allergen risk management by the food industry. 35 Such an approach would utilize a statistical system to determine which variables to use and the weighting to be applied to each of them.
Constructing an objective score would require data from allergic reactions experienced by a large population of patients who have undergone a comprehensive clinical evaluation including all the clinical manifestations of the reactions and a confirmation of their allergy diagnosis by the criterion standard diagnostic test. The challenge is that the severity of each allergic reaction needs to be quantified to provide an endpoint against which a model can be generated using the available clinical variables. Such a criterion standard measure for severity does not currently exist; the best approximate we have is likely to be a consensus severity assessment made by a large multidisciplinary group of experts.
Patients would be assigned to a grade according to their most severe symptom/sign, for example, grade 2 may include symptoms of grade 1 and grade 2. These grades would be generated using the approach described in the text. Grades would have the ability to be easily translated into clinical management, although individual patient characteristics and circumstances need to be taken into account so that different patients might be instructed to use epinephrine at different grades according to their risk profile.
| HOW SHOULD WE VALIDATE A NEW HARMONIZE D SEVE RITY SCORIN G SYSTEM?
A new severity scoring system would need to be validated to ensure that it provided an accurate assessment of severity in different populations at different time points. There are a number of accepted steps in this process. whether or not they feel that it is appropriate for their needs. Some refinement will probably be required to ensure that the approach is optimized for use in different clinical setting.
External validation
The refined new severity scoring system would ideally then need to be validated statistically using external data. Given the aim of developing one harmonized score, this would require extensive research and cover a number of different areas, such as assessing it against the use of epinephrine and high dependency care admission. This likely to prove challenging as both epinephrine use and admission vary between healthcare systems and physicians. Criteria for validity would need to be set in advance.
Cross-sectional validity would focus on the ability of the scoring system to differentiate between those experiencing outcomes of varying severities and also in comparing predicted with actual observed outcomes using standard parameters developed to assess the validity of models. An ideal score would need to function in Hospital admission data would be available from the UK Imperial PICAnet 39 and the Malaga database. 40 All of these databases would need to be carefully assessed in terms of their strengths and limitations, with a combination of datasets providing the best option.
| IMPACT ASSESSMENT
Following derivation and external validation, it is critical to assess whether the new scoring system is used as intended and translates into improved clinical outcomes (eg, improved decision-making in reactions, reduced risk, and better quality of life). It is also important to ensure that it does not result in important unintended consequences. This is ideally assessed using a randomized controlled trial (RCT) in which the new scoring system is compared with usual care; depending on the likely risk of contamination between intervention and control arms, a cluster design may be needed with different trial sites randomized to different arms. 41 If a formal experimental design is not possible, a quasi-experimental design could be employed (eg, an interrupted time series or a controlled before-after design)
although it should be noted that these alternative approaches are inherently at increased risk of bias when compared to a RCT. 
| IMPLEMEN TATION

| SUMMARY AND CONCLUSIONS
The accurate assessment and communication of potential severity of acute allergic reactions are important to patients, clinicians, researchers, food industry, and public health authorities. Many severity scoring systems are available, usually within the context of one group of allergens sources. However, none of the scoring systems has been developed using the gold standard method for the development of measurement and/or prognostic tools. Furthermore, none of these scoring systems has been validated. A validated reaction severity scoring system is needed to standardize patient monitoring. We propose an approach to developing a harmonized scoring system for acute allergic reactions that are based on a data-driven method, informed by clinical and patient experience as well as by the perspectives of other stakeholders. We envisage two levels of details:
an ordinal three-grade-based format and a continuous scoring system giving a continuum from mild to severe reactions that are clinically meaningful. This would allow the same system to be used by patients, clinicians, researchers, the food industry, and public health regulators. The new approach would need to be tested for reliability and validity using gold standard methods in a range of settings and populations. We propose that common epidemiological, clinical observational, and clinical interventional datasets should be collected to promote future collaboration, cross-validation, and refinement of the severity scoring system. For a harmonized system to be successful, an implementation strategy would be required and its impact would need to be assessed. Finally, severity should be considered as just one of a range of important aspects of risk assessment and risk management of allergic diseases. To determine the optimal management of a reaction for a patient, assessed severity needs to be integrated with the clinical context, for example, the dose of allergen, route of contact, rapidity of onset, and other intrinsic (patientrelated) and extrinsic factors.
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